Login / Signup

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Michail VikelisEmmanouil V DermitzakisGeorgia XiromerisiouDimitrios RallisPanagiotis SoldatosPantelis LitsardopoulosDimitrios RikosHaralabos P Kalofonos
Published in: Journal of clinical medicine (2023)
fremanezumab appears to be effective as a preventive treatment in difficult-to-treat CM patients with and without PCs while also being beneficial in reducing the severity of comorbid anxiety and/or depression.
Keyphrases
  • sleep quality
  • depressive symptoms
  • cross sectional
  • combination therapy
  • double blind